AlphaRx is a specialty pharmaceutical company that applies proprietary drug delivery technologies to reformulate FDA approved drugs to achieve improved efficacy and patient compliance.

AlphaRx uses safe carrier components that the FDA classifies as GRAS (generally regarded as safe) which cuts down on approval times and costs. They are patentable, flexible and can be modified to apply to a variety of drugs and therapeutic products.

AlphaRx has carefully chosen products for its’ pipeline that maximize the therapeutic value of our discoveries and technologies. These products have significant  market sales potential, when approved for use, and a range of times (from months to years) which may be necessary to achieve Government approvals. AlphaRx’s approach anticipates a  decrease in the time and capital expense necessary to achieve drug approvals and concurrently, a positive cash flow position for the company, enhancing shareholder value and long-term success for the long-term.

Our Mission

Alpha is the first letter of the Greek alphabet. Its' English language usage defines something which is pre-eminent, at the foundation or forefront in importance and influence.

AlphaRx's goal is to become preminent in the development of effective and innovative medicines and drug delivery platforms to address the unmet needs of patients and improve their health, longevity and quality of life.

We adhere to certain values in achieving this goal: conducting our activities with the highest of ethical standards, within the framework of  an entrepreneurial culture, in an atmosphere of partnership with our employees and collaborators and with an unrelenting passion and drive for excellence.

We aspire to the reality that these values be reflected in all that we do, to the benefit of our patients, shareholders and society as a whole.